FOR PATIENTS · SOURCE READING

Treatment of locally advanced or metastatic liver cancer

Source: Liver Cancer Treatment, National Cancer Institute.

Source updated: May 8, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Treatment of locally advanced or metastatic liver cancer may include:

Source links and citations

transarterial embolization (TAE) or transarterial chemoembolization (TACE) in people with locally advanced liver cancer

bevacizumab, cabozantinib, lenvatinib, ramucirumab, regorafenib, or sorafenib

atezolizumab with bevacizumab or cabozantinib, durvalumab with tremelimumab, nivolumab with ipilimumab, or pembrolizumab

radiation therapy

Preserved source evidence · Independent clinical review pending · Not medical advice